Preventative Effect of Montelukast in Mild To Moderate Contrast-Induced Acute Kidney Injury in Rats Via Nadph Oxidase 4, P22phox and Nuclear Factor Kappa-B Expressions
| dc.contributor.author | Simsek, Oguzhan | |
| dc.contributor.author | Baris, Elif | |
| dc.contributor.author | Ural, Cemre | |
| dc.contributor.author | Incir, Canet | |
| dc.contributor.author | Aydemir, Selma | |
| dc.contributor.author | Gumustekin, Mukaddes | |
| dc.contributor.author | Arici, Mualla Aylin | |
| dc.date.accessioned | 2025-04-25T19:49:38Z | |
| dc.date.available | 2025-04-25T19:49:38Z | |
| dc.date.issued | 2025 | |
| dc.description | Baris, Elif/0000-0001-6838-7932; Simsek, Oguzhan/0000-0003-2756-8440 | en_US |
| dc.description.abstract | Reactive oxygen species (ROS) generation, inflammation and apoptosis are observed in contrast-induced acute kidney injury (CI-AKI). NOX4, isoform of NADPH oxidase main regulatory enzyme for ROS generation, is mostly expressed in the kidney and co-localized with p22phox. It is investigated the effect of antioxidant, anti-inflammatory and anti-apoptotic montelukast pre-treatment on expression of NOX4, p22phox and NF-kappa B in preventing CI-AKI in rats in this study. Wistar male rats randomized into four groups: 1. Control (C), 2. CI-AKI (iohexol; 3 g iodine/kg), 3. Montelukast (10 mg/kg) (M), 4. M + CI-AKI. Rats sacrificed on the 7th day. Urine and serum creatinine and serum Kidney injury molecule-1 (KIM-1) levels measured. NF-kappa B, NOX-4, p22phox mRNA and protein expressions, TNF-alpha, KIM-1 mRNA expressions, ROS and caspase-3 evaluated from kidney tissue. Histological injury scored. ANOVA and Kruskal-Wallis tests were used for analysis parametric and nonparametric data, respectively. p < 0.05 considered statistically significant. Tubular injury score, KIM-1 and caspase-3 levels increased in CI-AKI group compared to C group (p < 0.05). TNF-alpha, NF-kappa B, NOX-4, p22phox, KIM-1 mRNA expressions and ROS levels increased in CI-AKI group compared to C group (p < 0.001 and p < 0.05). NF-kappa B, NOX-4, p22phox protein expressions increased in CI-AKI group compared to C group (p < 0.05) and decreased in the M + CI-AKI group compared to CI-AKI group (p < 0.01, p < 0.05, p < 0.05). TNF-alpha, NF-kappa B, NOX-4, p22phox, KIM-1 mRNA expressions and ROS levels decreased with montelukast pre-treatment (p < 0.001). One of the mechanism of increased ROS level in the CI-AKI model is related the increase the expression of NOX4 and p22phox and montelukast pre-treatment has a protective effect by decreasing NOX4 and p22phox mRNA and protein expressions. | en_US |
| dc.description.sponsorship | Dokuz Eylul University Research Foundation [2019.KB.SAG.068] | en_US |
| dc.description.sponsorship | This project was supported by Dokuz Eyluel University Research Foundation with the grant number 2019.KB.SAG.068. | en_US |
| dc.identifier.doi | 10.1007/s11255-025-04378-5 | |
| dc.identifier.issn | 0301-1623 | |
| dc.identifier.issn | 1573-2584 | |
| dc.identifier.scopus | 2-s2.0-85218711454 | |
| dc.identifier.uri | https://doi.org/10.1007/s11255-025-04378-5 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/6047 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.relation.ispartof | International Urology and Nephrology | |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Contrast-Induced Nephropathy | en_US |
| dc.subject | Montelukast | en_US |
| dc.subject | Oxidative Stress | en_US |
| dc.subject | Nox4 | en_US |
| dc.subject | P22Phox | en_US |
| dc.title | Preventative Effect of Montelukast in Mild To Moderate Contrast-Induced Acute Kidney Injury in Rats Via Nadph Oxidase 4, P22phox and Nuclear Factor Kappa-B Expressions | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Baris, Elif/0000-0001-6838-7932 | |
| gdc.author.id | Simsek, Oguzhan/0000-0003-2756-8440 | |
| gdc.author.scopusid | 57214450798 | |
| gdc.author.scopusid | 57328351600 | |
| gdc.author.scopusid | 56804887400 | |
| gdc.author.scopusid | 57221411184 | |
| gdc.author.scopusid | 57214692710 | |
| gdc.author.scopusid | 6508158631 | |
| gdc.author.scopusid | 24179281500 | |
| gdc.author.wosid | Arici, Mualla/Aas-9385-2020 | |
| gdc.author.wosid | Simsek, Oguzhan/Aag-1927-2021 | |
| gdc.author.wosid | /Q-1679-2019 | |
| gdc.author.wosid | Cavdar, Zahide/T-7394-2019 | |
| gdc.author.wosid | Özbal, Seda/Aaa-7762-2020 | |
| gdc.author.wosid | Baris, Elif/Hpf-4375-2023 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | [Simsek, Oguzhan; Baris, Elif] Dokuz Eylul Univ, Grad Sch Hlth Sci, Pharmacol, TR-35040 Izmir, Turkiye; [Baris, Elif] Izmir Univ Econ, Fac Med, Dept Med Pharmacol, TR-35040 Izmir, Turkiye; [Ural, Cemre; Cavdar, Zahide] Dokuz Eylul Univ, Grad Sch Hlth Sci, Dept Mol Med, TR-35040 Izmir, Turkiye; [Incir, Canet; Gumustekin, Mukaddes] Dokuz Eylul Univ, Fac Med, Dept Med Pharmacol, TR-35040 Izmir, Turkiye; [Aydemir, Selma] Dokuz Eylul Univ, Grad Sch Hlth Sci Histol & Embryol, TR-35040 Izmir, Turkiye; [Yilmaz, Osman] Dokuz Eylul Univ, Grad Sch Hlth Sci, Dept Lab Anim Sci, TR-35040 Izmir, Turkiye; [Ozbal, Seda] Dokuz Eylul Univ, Fac Med, Dept Histol & Embryol, TR-35340 Izmir, Turkiye; [Arici, Mualla Aylin] Dokuz Eylul Univ, Fac Med, Dept Med Pharmacol, TR-35340 Izmir, Turkiye | en_US |
| gdc.description.endpage | 2325 | |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.startpage | 2313 | |
| gdc.description.volume | 57 | |
| gdc.description.woscitationindex | Science Citation Index Expanded | |
| gdc.description.wosquality | Q3 | |
| gdc.identifier.openalex | W4407813312 | |
| gdc.identifier.pmid | 39982657 | |
| gdc.identifier.wos | WOS:001428097200001 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 2.0 | |
| gdc.oaire.influence | 2.534938E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.popularity | 4.2350274E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 5.8297 | |
| gdc.openalex.normalizedpercentile | 0.96 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.crossrefcites | 1 | |
| gdc.plumx.mendeley | 3 | |
| gdc.plumx.pubmedcites | 1 | |
| gdc.plumx.scopuscites | 2 | |
| gdc.scopus.citedcount | 2 | |
| gdc.virtual.author | Barış, Elif | |
| gdc.wos.citedcount | 2 | |
| relation.isAuthorOfPublication | 71e21c57-4f39-4d2d-8ae5-0c37922b593a | |
| relation.isAuthorOfPublication.latestForDiscovery | 71e21c57-4f39-4d2d-8ae5-0c37922b593a | |
| relation.isOrgUnitOfPublication | 4cbb0a74-ee1a-438b-b714-b8ef253df94b | |
| relation.isOrgUnitOfPublication | fbc53f3e-d1d3-4168-afd8-e42cd20bddd9 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 4cbb0a74-ee1a-438b-b714-b8ef253df94b |
Files
Original bundle
1 - 1 of 1
